cetuximab used in combination with irinotecan is indicated for the treatment of egfrexpressing metastatic colorectal carcinoma in patients who are refractory to irinotecanbased chemotherapy cetuximab administered as a single agent is indicated for the treatment of egfrexpressing metastatic colorectal carcinoma in patients who are intolerant to irinotecanbased chemotherapy
for treatment of prostate cancer endometriosis uterine fibroids and premature puberty
for the intralesional treatment of refractory or recurring external condylomata acuminata
for the treatment of type 1 or 2 diabetes mellitus to be used in conjunction with an intermediate or longacting insulin except when used in a continuous insulin infusion pump
for the treatment of complicated skin and skin structure infections caused by susceptible strains of grampositive microorganisms
may be used as a first line agent to treat uncomplicated hypertension isolated systolic hypertension and left ventricular hypertrophy may be used as a first line agent to delay progression of diabetic nephropathy losartan may be also used as a second line agent in the treatment of congestive heart failure systolic dysfunction myocardial infarction and coronary artery disease in those intolerant of ace inhibitors
for the maintenance treatment of asthma as a prophylactic therapy
for the management of anxiety disorders and for treatment of status epilepticus
for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative postoperative or other emergent circumstances where short term control of ventricular rate with a shortacting agent is desirable also used in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention
shortterm up to 16 weeks treatment of erosive esophagitis
used in combination with acetaminophen or aspirin and caffeine for its sedative and relaxant effects in the treatment of tension headaches migraines and pain
for the control of generalized tonicclonic grand mal and complex partial psychomotor temporal lobe seizures and prevention and treatment of seizures occurring during or following neurosurgery
for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases such as emphysema and chronic bronchitis
indicated for the treatment of parkinsons disease and extrapyramidal reactions caused by drugs
for the symptomatic relief of cough has also been applied locally in the oral cavity in adults by releasing the drug from the liquidfilled capsules to provide oropharyngeal anesthesia for conscious intubation
for the treatment of obesity
